Advertisement
For high-risk and older patients with previously untreated chronic lymphocytic leukemia

Ibrutinib, Venetoclax Active in High-Risk, Seniors With CLL

0
Findings seen in phase 2 study of combo regimen for first-line treatment of chronic lymphocytic leukemia
The first test to detect the Zika virus in human blood has been approved by the U.S. Food and Drug Administration.

FDA Approves First Test for Zika in Human Blood

0
The ZIKV Detect 2.0 IgM Capture ELISA is made by Seattle-based InBios
Potentially inappropriate prescribing is tied to increased health care utilization and poor outcomes among older individuals seen in primary care practices

Inappropriate Prescribing Leads to Poor Outcomes in Older Adults

0
Potentially inappropriate prescribing tied to ED visits, adverse drug events, functional decline
Reading clinical notes can help patients to understand why medications are prescribed and improves medication adherence for some patients

Reading Visit Notes May Improve Medication Management

0
Patients say note reading helps them understand why meds are prescribed, makes them feel in control
For patients with newly diagnosed multiple myeloma

Daratumumab Cuts Risk for Progression in Multiple Myeloma

0
Adding daratumumab to lenalidomide + dexamethasone beneficial for newly diagnosed multiple myeloma
The prevalence of diagnosed diabetes has plateaued during the last eight years

Recent Plateauing Seen in Prevalence of Diagnosed Diabetes

0
Following increase from 1990 to 2007, incidence rates significantly decreased since 2007
For patients with intracerebral hemorrhage

Antiplatelets Do Not Up Recurrence in Intracerebral Hemorrhage

0
In population with cerebral microbleeds, no increased risk seen for those starting antiplatelet therapy
Piqray (alpelisib) tablets were approved for the treatment of hormone receptor-positive

First PI3K Inhibitor Approved for Metastatic, Advanced Breast Cancer

0
Piqray approved for HR-positive, HER2-negative, PIK3CA-mutated, metastatic or advanced breast cancer
The first gene therapy has been approved to treat children younger than 2 years with spinal muscular atrophy

FDA Approves First Gene Therapy for Spinal Muscular Atrophy

0
Patients treated with Zolgensma have shown improvement in reaching developmental motor milestones
Weight management medications are underutilized among veterans

Meds for Weight Management Underutilized Among Veterans

0
Only 1 percent of veterans enrolled in weight management programs receive medications